APA (7th ed.) Citation

Y, T., Y, A., S, A., Y, T., & F, T. (2026). Exceptional and Durable Complete Response to Ado-Trastuzumab Emtansine in HER2-Positive Metastatic Breast Cancer: A Case Report. Cureus, 18(1), e102669. https://doi.org/10.7759/cureus.102669

Chicago Style (17th ed.) Citation

Y, Tashima, Araki Y, Araki S, Tahara Y, and Tanaka F. "Exceptional and Durable Complete Response to Ado-Trastuzumab Emtansine in HER2-Positive Metastatic Breast Cancer: A Case Report." Cureus 18, no. 1 (2026): e102669. https://doi.org/10.7759/cureus.102669.

MLA (9th ed.) Citation

Y, Tashima, et al. "Exceptional and Durable Complete Response to Ado-Trastuzumab Emtansine in HER2-Positive Metastatic Breast Cancer: A Case Report." Cureus, vol. 18, no. 1, 2026, p. e102669, https://doi.org/10.7759/cureus.102669.